Neuphoria Therapeutics NEUP
NASDAQ NEUP
$3.48 +0.09 (+2.65%)
At close: Oct 21, 2026 · 4:00 PM EDT

Neuphoria Therapeutics (NEUP) Revenue (2024 - 2025)

Updated

Neuphoria Therapeutics' Revenue came in at $1.17 million for FY2026 (year ended Jun 30, 2026), down 92.5% from $15.65 million in FY2025.

Analysis

Neuphoria Therapeutics (NEUP) Revenue (2024 - 2025) Analysis & Trends

Going back to FY2020, Neuphoria Therapeutics' Revenue data covers 5 fiscal years.

  • Revenue carries a four-year compound annual growth rate of 57.9% (FY2022 to FY2026).
  • The FY2026 figure represents the lowest annual Revenue since FY2023.
  • Per Business Quant, earlier fiscal years put Revenue at $15.65 million in FY2025, $14,735 in FY2023 (-92.2%) and $188,833 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 16.99 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 15.03 Bn
10 Neuphoria Therapeutics 435.69 Mn 360.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -13,267.00
Mar 31, 2025 15.00 Mn
Dec 31, 2024 662,715.00
API Access

Neuphoria Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=NEUP&period=max&api_key=YOUR_API_KEY